Omega Therapeutics, Inc. (OMGA)
NASDAQ: OMGA · Real-Time Price · USD
0.790
+0.030 (3.97%)
At close: Nov 20, 2024, 4:00 PM
0.810
+0.020 (2.56%)
Pre-market: Nov 21, 2024, 4:11 AM EST
Omega Therapeutics Employees
As of December 31, 2023, Omega Therapeutics had 94 total employees, including 93 full-time and 1 part-time employees. The number of employees decreased by 23 or -19.66% compared to the previous year.
Employees
94
Change (1Y)
-23
Growth (1Y)
-19.66%
Revenue / Employee
$86,117
Profits / Employee
-$777,574
Market Cap
43.58M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 94 | -23 | -19.66% |
Dec 31, 2022 | 117 | 37 | 46.25% |
Dec 31, 2021 | 80 | - | - |
Related Stocks
Company Name | Employees |
---|---|
NeueHealth | 1,252 |
Fortress Biotech | 186 |
Accelerate Diagnostics | 134 |
Xilio Therapeutics | 73 |
LAVA Therapeutics | 37 |
Citius Pharmaceuticals | 22 |
Reviva Pharmaceuticals Holdings | 15 |
Nexalin Technology | 6 |
OMGA News
- 5 weeks ago - Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings - GlobeNewsWire
- 2 months ago - Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications - GlobeNewsWire
- 3 months ago - Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research - GlobeNewsWire
- 3 months ago - Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress - GlobeNewsWire
- 5 months ago - Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors - GlobeNewsWire
- 6 months ago - Omega Therapeutics To Participate In Two Upcoming Investor Conferences - GlobeNewsWire
- 6 months ago - Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer - GlobeNewsWire
- 7 months ago - Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers - GlobeNewsWire